<p>Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin</p>

SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential

The prevalence of type 2 diabetes mellitus (T2DM) has been increasing worldwide. Therefore, a novel therapeutic strategy by which to prevent T2DM is urgently required. Calorie restriction (CR) can retard the aging processes, and delay the onset of numerous age-related diseases including diabetes. Metabolic CR mimetics may be therefore included as novel therapeutic targets for T2DM. Sirtuin 1 (S...

potential therapeutic effects of nitrate/nitrite and type 2 diabetes mellitus

Type 2 Diabetes, Therapeutic Targets and Potential Drugs: A Review

Type 2 diabetes mellitus (T2DM) is very common diseases and results from a combination of defects in insulin secretion and insulin action, either of which may predominate. This type of diabetes accounts for 90 to 95% of all diabetic patients. The current prevalence of T2DM is 2.4% in the rural population and 11.6% in the urban population of India. The present review gives a brief introduction t...

Dietary Diabetes Risk Reduction Score, Race and Ethnicity, and Risk of Type 2 Diabetes in Women

OBJECTIVE To evaluate racial and ethnic differences in the association between a dietary diabetes risk reduction score and incidence of type 2 diabetes in U.S. white and minority women. RESEARCH DESIGN AND METHODS We followed 156,030 non-Hispanic white (NHW), 2,026 Asian, 2,053 Hispanic, and 2,307 black women in the Nurses' Health Study (NHS) (1980-2008) and NHS II (1991-2009). A time-updated...

medicinal plants in type 2 diabetes: therapeutic and economical aspects

---